Novavax Inc. Stock Rises Tuesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) advanced 1.22% to $12.41 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.01% to 10,742.63 and the Dow Jones Industrial Average rising 0.56% to 33,704.10. This was the stock's second consecutive day of gains. Novavax Inc. closed $123.28 below its 52-week high ($135.69), which the company reached on January 12th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.24% to $175.16, Pfizer Inc. (PFE) fell 1.59% to $47.62, and Merck & Co. Inc. (MRK) rose 0.39% to $110.81. Trading volume (6.0 M) remained 611,542 below its 50-day average volume of 6.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2023.
(END) Dow Jones Newswires
January 10, 2023 17:15 ET (22:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.